醋酸环丙孕酮停药后骨脑膜瘤骨内与脑膜成分的体积变化
本研究回顾17例患者21个骨脑膜瘤,用四种肿瘤生长模型拟合体积动态。Gompertz模型拟合最佳;停药后脑膜成分95%缩小,骨内成分全部持续生长;两成分体积变化显著相关(rho=0.49,p=0.03);激素受体表达无差异。
要点
- CPA停药后脑膜成分多缩小,骨内成分均继续生长。
- Gompertz模型最能拟合骨脑膜瘤体积变化。
- 两成分体积变化显著相关(rho=0.49,p=0.03)。
核心结论
- 骨脑膜瘤脑膜与骨内成分对CPA停药反应不同,但生长动态仍相关。
研究设计与样本
- 回顾性研究纳入17例患者21个CPA治疗期间诊断的骨脑膜瘤,多时间点测量两成分体积并用四种模型拟合,对4个手术肿瘤行免疫组化激素受体分析。
主要发现
- 停药后脑膜成分95%肿瘤体积缩小(40%大幅下降,55%小幅下降)。
- 骨内成分所有病例持续生长:40%生长减缓、45%线性生长、15%假指数生长。
- 两成分体积变化显著相关(rho=0.49,p=0.03)。
- 4个手术肿瘤中两成分激素受体表达无差异。
关键数值与推荐
- Gompertz肿瘤生长模型拟合数据最准确。
- 脑膜成分体积缩小见于95%肿瘤,其中40%大幅下降、55%小幅下降。
- 骨内成分持续生长:40%减缓、45%线性、15%假指数。
- 两成分体积变化相关系数rho=0.49,p=0.03。
临床怎么用
- CPA停药后需分别评估骨脑膜瘤脑膜与骨内成分的体积变化。
- 骨内成分可能持续生长,即使脑膜成分缩小也应继续影像随访。
局限性
- 回顾性设计且样本量小(17例患者21个肿瘤)。
- 仅4个肿瘤行激素受体免疫组化分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Progestin exposure, such as with cyproterone acetate (CPA), could increase the risk of developing osteomeningiomas (OMs). This study investigated the volumetric dynamics of the meningeal and intraosseous components of these tumors and their correlation following CPA discontinuation. METHODS: This retrospective study included 17 patients with 21 OMs diagnosed during ongoing CPA treatment. Volumes of the meningeal and intraosseous components of the OMs were measured at multiple time points. Volume dynamics over time were modeled using linear, exponential, power, and Gompertz tumor growth models. Hormone receptor expression in both components was evaluated via immunohistochemical analysis in the 4 tumors on which surgery was performed. RESULTS: The Gompertz tumor growth model was the most accurate in fitting the data. After CPA cessation, the meningeal component showed volume reduction in 95% of tumors (a substantial decrease in 40% and a modest decrease in 55% of tumors). The intraosseous component exhibited sustained growth in all cases, characterized by three distinct dynamics: slowing growth (40%), linear growth (45%), and pseudo-exponential growth (15%). A significant correlation was observed between the volumetric courses in the two components (rho = 0.49, p = 0.03). Hormone receptor analysis revealed no differences in expression between the two components. CONCLUSIONS: While the meningeal and intraosseous components of OMs respond differently to CPA withdrawal, their growth dynamics remain correlated.
引用
- Constanthin PE, Montalibet V, Quang ML, et al. Volumetric courses of the intraosseous and meningeal components of osteomeningiomas after cyproterone acetate treatment withdrawal. J Neurosurg. 2025. PMID: 40972025. doi:10.3171/2025.4.JNS25252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。